|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,500,000 |
Market
Cap: |
2.01(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$38.65 - $65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,000 |
384,322 |
579,546 |
794,601 |
Total Sell Value |
$42,551 |
$21,525,712 |
$32,066,990 |
$40,646,784 |
Total People Sold |
1 |
4 |
8 |
10 |
Total Sell Transactions |
2 |
10 |
25 |
62 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shandell Jason B. |
President and General Counsel |
|
2018-11-09 |
4 |
OE |
$10.46 |
$168,354 |
D/D |
16,095 |
215,600 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2018-11-08 |
4 |
AS |
$20.00 |
$21,680 |
D/D |
(1,084) |
54,392 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2018-11-08 |
4 |
AS |
$20.50 |
$123,000 |
D/D |
(6,000) |
40,763 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2018-11-08 |
4 |
OE |
$11.41 |
$68,460 |
D/D |
6,000 |
46,763 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2018-11-08 |
4 |
AS |
$20.26 |
$517,883 |
D/D |
(25,312) |
81,324 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2018-11-08 |
4 |
OE |
$11.33 |
$224,334 |
D/D |
19,800 |
106,636 |
|
- |
|
Shandell Jason B. |
President and General Counsel |
|
2018-11-08 |
4 |
AS |
$20.68 |
$748,586 |
D/D |
(36,201) |
199,505 |
|
- |
|
Shandell Jason B. |
President and General Counsel |
|
2018-11-08 |
4 |
OE |
$10.46 |
$385,711 |
D/D |
36,201 |
235,706 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2018-08-16 |
4 |
AS |
$17.59 |
$42,333 |
D/D |
(2,407) |
86,836 |
|
- |
|
Prins Richard K |
Director |
|
2018-08-14 |
4 |
S |
$17.82 |
$178,180 |
D/D |
(10,000) |
35,434 |
|
- |
|
Prins Richard K |
Director |
|
2018-08-14 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
45,434 |
|
- |
|
Shandell Jason B. |
President and General Counsel |
|
2018-07-11 |
4 |
AS |
$16.77 |
$241,422 |
D/D |
(14,399) |
199,505 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2018-07-09 |
4 |
AS |
$16.46 |
$53,498 |
D/D |
(3,250) |
89,243 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2018-07-02 |
4 |
D |
$15.39 |
$2,554,248 |
I/I |
(165,968) |
1,366,706 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2018-07-02 |
4 |
OE |
$12.02 |
$2,242,831 |
I/I |
186,545 |
1,532,674 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2018-07-02 |
4 |
D |
$15.39 |
$4,378,701 |
D/D |
(284,516) |
2,115,894 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2018-07-02 |
4 |
OE |
$12.02 |
$3,844,847 |
D/D |
319,791 |
2,400,410 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2018-06-15 |
4 |
D |
$16.88 |
$2,262 |
D/D |
(134) |
55,476 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2018-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,474 |
40,763 |
|
- |
|
Zasloff Michael A |
Director |
|
2018-06-12 |
4 |
S |
$16.52 |
$247,842 |
D/D |
(15,000) |
29,845 |
|
- |
|
Lee Howard |
Director |
|
2018-06-08 |
4 |
D |
$16.67 |
$29,239 |
D/D |
(1,754) |
123,381 |
|
- |
|
Shohet Stephen B. |
Director |
|
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,590 |
30,706 |
|
- |
|
Koo Richard |
Director |
|
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,590 |
241,928 |
|
- |
|
Lee Howard |
Director |
|
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,590 |
125,135 |
|
- |
|
Zasloff Michael A |
Director |
|
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,590 |
44,845 |
|
- |
|
956 Records found
|
|
Page 23 of 39 |
|
|